Toggle Navigation
Home
News and Events
The Project
Partners
ESRs
Publications
ELBA Internal Portal
Contacts
Search for:
Publications
'Analysis of Extracellular Vesicle MRNA Derived from Plasma Using the NCounter Platform'
Jillian W. P. Bracht, Ana Gimenez-Capitan, Chung-Ying Huang, Nicolas Potie, Carlos Pedraz-Valdunciel, Sarah Warren, Rafael Rosell, and Miguel A. Molina-Vila.
Scientific Reports, 2021.
https://doi.org/10.1038/s41598-021-83132-0
‘Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform’
Ana Giménez-Capitán, Jillian Bracht, Juan José García, Núria Jordana-Ariza, Beatriz García, Mónica Garzón, Clara Mayo-de-las-Casas, et al.
Clinical Chemistry, 2021.
https://doi.org/10.1093/clinchem/hvaa248
‘Liquid Biopsies: Potential and Challenges’
Isabel Heidrich*, Lucija Ačkar*, Parinaz Mossahebi Mohammadi*, and Klaus Pantel.
International Journal of Cancer, 2021.
https://doi.org/10.1002/ijc.33217
‘Clinical Relevance of Blood-Based CtDNA Analysis: Mutation Detection and Beyond’
Laura Keller, Yassine Belloum, Harriet Wikman, and Klaus Pantel.
British Journal of Cancer, 2021.
https://doi.org/10.1038/s41416-020-01047-5
‘isomiRs–Hidden Soldiers in the MiRNA Regulatory Army, and How to Find Them?’
Ilias Glogovitis, Galina Yahubyan, Thomas Würdinger, Danijela Koppers-Lalic, and Vesselin Baev.
Biomolecules, 2020.
https://doi.org/10.3390/biom11010041
‘Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas’
Giulia Mantini, Laura L. Meijer, Ilias Glogovitis, Sjors G. J. G. In ‘t Veld, Rosita Paleckyte, Mjriam Capula, Tessa Y. S. Le Large, et al.
Cancers, 2020.
https://doi.org/10.3390/cancers13010066
‘Circulating Platelets as Liquid Biopsy Sources for Cancer Detection’
Mafalda Antunes-Ferreira, Danijela Koppers-Lalic, and Thomas Würdinger.
Molecular Oncology, 2020.
https://doi.org/10.1002/1878-0261.12859
‘Do Malignant Cells Sleep at Night?’
Luis Enrique Cortés-Hernández, Zahra Eslami-S, Antoine M. Dujon, Mathieu Giraudeau, Beata Ujvari, Frédéric Thomas, and Catherine Alix-Panabières.
Genome Biology, 2020.
https://doi.org/10.1186/s13059-020-02179-w
‘Commentary: Safety and Feasibility of CRISPR-Edited T Cells in Patients with Refractory Non-Small-Cell Lung Cancer’
Rafael Rosell, Martyna Filipska, Imane Chaib, David Lligé, and Fernando Laguia.
Frontiers in Oncology, 2020
https://doi.org/10.3389/fonc.2020.01726
‘Liquid Biopsy to Detect Circulating Tumor Cells: Is It Ready for a Value Proposition in Laboratory Medicine?’
Luis Enrique Cortés-Hernández, Zahra Eslami-S, and Catherine Alix-Panabières.
The Journal of Applied Laboratory Medicine, 2020
https://doi.org/10.1093/jalm/jfaa115
‘DNA in Extracellular Vesicles: Biological and Clinical Aspects’
Julia Elzanowska, Christine Semira, and Bruno Costa-Silva.
Molecular Oncology, 2020
https://doi.org/10.1002/1878-0261.12777
‘Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells’
Zahra Eslami-S*, Luis Enrique Cortés-Hernández*, and Catherine Alix-Panabières.
Cells, 2020
https://doi.org/10.3390/cells9081836
‘The Metastatic Cascade as the Basis for Liquid Biopsy Development’
Zahra Eslami-S*, Luis Enrique Cortés-Hernández*, and Catherine Alix-Panabières.
Frontiers in Oncology, 2020
https://doi.org/10.3389/fonc.2020.01055
‘The Different Facets of Liquid Biopsy: A Kaleidoscopic View’
Zahra Eslami-S*, Luis Enrique Cortés-Hernández*, Laure Cayrefourcq, and Catherine Alix-Panabières.
Cold Spring Harbor Perspectives in Medicine, 2020
https://doi.org/10.1101/cshperspect.a037333
‘The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance’
Hassan Dianat-Moghadam, Mehdi Azizi, Zahra Eslami-S, Luis Enrique Cortés- Hernández, Maryam Heidarifard, Mohammad Nouri, and Catherine Alix-Panabières.
Cancers, 2020
https://doi.org/10.3390/cancers12040867
‘Circulating Tumor Cell as the Functional Aspect of Liquid Biopsy to Understand the Metastatic Cascade in Solid Cancer’
Luis Enrique Cortés-Hernández*, Zahra Eslami-S* and Catherine Alix-Panabières.
Molecular Aspects of Medicine, 2020
https://doi.org/10.1016/j.mam.2019.07.008
‘Circulating Tumor Cells: Moving Forward into Clinical Applications’
Zahra Eslami-S*, Luis Enrique Cortés-Hernández*, and Catherine Alix-Panabières.
Precision Cancer Medicine, 2020
https://doi.org/10.21037/pcm.2019.11.07
‘Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application'
Luis Enrique Cortés-Hernández*, Zahra Eslami-S*, Klaus Pantel, and Catherine Alix- Panabières.
Clinical Chemistry, 2020
https://doi.org/10.1373/clinchem.2019.303586
‘Liquid Biopsy Diagnosis of CNS Metastases’ in Central Nervous System Metastases
Mafalda Antunes Ferreira*, Silvia D’Ambrosi*, Thomas Würdinger, Pieter Wesseling, and Danijela Koppers-Lalic.
Springer International Publishing, 2020
https://doi.org/10.1007/978-3-030-23417-1_6
‘BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale’
Jillian W. P. Bracht, Niki Karachaliou, Trever Bivona, Richard B. Lanman, Iris Faull, Rebecca J. Nagy, Ana Drozdowskyj, et al.
Cancers, 2019
https://doi.org/10.3390/cancers11091381
‘SRNAbench and SRNAtoolbox 2019: Intuitive Fast Small RNA Profiling and Differential Expression’
Ernesto Aparicio-Puerta, Ricardo Lebrón, Antonio Rueda, Cristina Gómez-Martín, Stavros Giannoukakos, David Jaspez, José María Medina, et al.
Nucleic Acids Research, 2019
https://doi.org/10.1093/nar/gkz415
‘Biological Therapies in Lung Cancer Treatment: Using Our Immune System as an Ally to Defeat the Malignancy’
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib, and Rafael Rosell.
Expert Opinion on Biological Therapy, 2019
https://doi.org/10.1080/14712598.2019.1582635
‘ARID1A Gene Driver Mutations in Lung Adenocarcinomas’
Niki Karachaliou, Jillian W. P. Bracht, and Rafael Rosell.
Journal of Thoracic Oncology, 2018
https://doi.org/10.1016/j.jtho.2018.07.099
‘The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring’
Jillian W. P. Bracht, Clara Mayo-de-las-Casas, Jordi Berenguer, Niki Karachaliou, and Rafael Rosell.
Current Oncology Reports, 2018
https://doi.org/10.1007/s11912-018-0720-z
‘Combining Plasma-Based Biosources to Predict Treatment Response in NSCLC Patients’
Jillian W. P. Bracht, Jordi Berenguer, Niki Karachaliou, Martyna Filipska, and Rafael Rosell.
Annals of Oncology, 2018
https://doi.org/10.1093/annonc/mdy246
